CC-99677

N/A

Report date: 2023/04/11 20:00:23
NME

Base Information

Drug NameCC-99677
Drug Alias NameCC-99677BMS-986371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 2 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 2
Therapy Area/IndicationsSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyCelgene Corp
Inactive CompaniesBristol-Myers Squibb (China) Investment Co LtdBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsSpondylitis, Ankylosing

Other Information

ATC CodeN/A
Related LinksN/A